NCT07022275

Safety Evaluation of THC-Free Hemp Protein Isolate

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 32 (estimated)
• Sponsor: National University of Natural Medicine · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The goal of this clinical trial is to evaluate the safety and tolerability of a THC-free hemp protein supplement in healthy adult volunteers aged 18-65 years who do not use cannabis or hemp-derived products. The main questions this study aims to answer are: Does twice-daily consumption of 20 grams of Agoge Hemp Protein Powder for 30 days result in detectable levels of THC-COOH, the primary metabolite of THC, in urine samples? Is the supplement well tolerated, and does it affect common clinical safety markers (e.g., liver and kidney function, inflammatory markers)? This is a single-arm study with no comparison group. All participants will: * Consume 20 grams of the hemp protein supplement twice daily for 30 days * Provide blood and urine samples at baseline and Day 30 * Complete weekly surveys assessing adherence, tolerability, and adverse events

Conditions

• Tolerability of Hemp Protein

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Hemp protein powder	Agoge Universal Hemp Protein Powder - A certified cannabinoid-free hemp protein powder.

Timeline

• Start date: 2025-03-15
• Primary completion: 2025-09-25
• Completion: 2025-09-25
• First posted: 2025-06-15
• Last updated: 2025-09-05

Locations

1 site across 1 country: United States